Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

537 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mixed 20-peptide cancer vaccine in combination with docetaxel and dexamethasone for castration-resistant prostate cancer: a randomized phase II trial.
Noguchi M, Arai G, Egawa S, Ohyama C, Naito S, Matsumoto K, Uemura H, Nakagawa M, Nasu Y, Eto M, Suekane S, Sasada T, Shichijo S, Yamada A, Kakuma T, Itoh K. Noguchi M, et al. Among authors: nasu y. Cancer Immunol Immunother. 2020 May;69(5):847-857. doi: 10.1007/s00262-020-02498-8. Epub 2020 Feb 5. Cancer Immunol Immunother. 2020. PMID: 32025848 Free PMC article. Clinical Trial.
[Prostate cancer gene therapy].
Nasu Y, Kumon H. Nasu Y, et al. Nihon Rinsho. 2005 Mar;63(3):485-90. Nihon Rinsho. 2005. PMID: 15773349 Review. Japanese.
Prostate-specific antigen 'bounce' after permanent 125I-implant brachytherapy in Japanese men: a multi-institutional pooled analysis.
Satoh T, Ishiyama H, Matsumoto K, Tsumura H, Kitano M, Hayakawa K, Ebara S, Nasu Y, Kumon H, Kanazawa S, Miki K, Egawa S, Aoki M, Toya K, Yorozu A, Nagata H, Saito S, Baba S. Satoh T, et al. Among authors: nasu y. BJU Int. 2009 Apr;103(8):1064-8. doi: 10.1111/j.1464-410X.2008.08234.x. Epub 2008 Nov 25. BJU Int. 2009. PMID: 19040526
A randomized phase II trial of personalized peptide vaccine plus low dose estramustine phosphate (EMP) versus standard dose EMP in patients with castration resistant prostate cancer.
Noguchi M, Kakuma T, Uemura H, Nasu Y, Kumon H, Hirao Y, Moriya F, Suekane S, Matsuoka K, Komatsu N, Shichijo S, Yamada A, Itoh K. Noguchi M, et al. Among authors: nasu y. Cancer Immunol Immunother. 2010 Jul;59(7):1001-9. doi: 10.1007/s00262-010-0822-4. Epub 2010 Feb 10. Cancer Immunol Immunother. 2010. PMID: 20146063 Free PMC article. Clinical Trial.
Maintenance therapy with bacillus Calmette-Guérin Connaught strain clearly prolongs recurrence-free survival following transurethral resection of bladder tumour for non-muscle-invasive bladder cancer.
Hinotsu S, Akaza H, Naito S, Ozono S, Sumiyoshi Y, Noguchi S, Yamaguchi A, Nagamori S, Terai A, Nasu Y, Kume H, Tomita Y, Tanaka Y, Samma S, Uemura H, Koga H, Tsushima T. Hinotsu S, et al. Among authors: nasu y. BJU Int. 2011 Jul;108(2):187-95. doi: 10.1111/j.1464-410X.2010.09891.x. Epub 2010 Dec 22. BJU Int. 2011. PMID: 21176079 Clinical Trial.
An Open-Label, Randomized Phase II Trial of Personalized Peptide Vaccination in Patients with Bladder Cancer that Progressed after Platinum-Based Chemotherapy.
Noguchi M, Matsumoto K, Uemura H, Arai G, Eto M, Naito S, Ohyama C, Nasu Y, Tanaka M, Moriya F, Suekane S, Matsueda S, Komatsu N, Sasada T, Yamada A, Kakuma T, Itoh K. Noguchi M, et al. Among authors: nasu y. Clin Cancer Res. 2016 Jan 1;22(1):54-60. doi: 10.1158/1078-0432.CCR-15-1265. Epub 2015 Nov 18. Clin Cancer Res. 2016. PMID: 26581246 Clinical Trial.
Phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer.
Matsubara N, Nagamori S, Wakumoto Y, Uemura H, Kimura G, Yokomizo A, Kikukawa H, Mizokami A, Kosaka T, Masumori N, Kawasaki Y, Yonese J, Nasu Y, Fukasawa S, Sugiyama T, Kinuya S, Hosono M, Yamaguchi I, Tsutsui H, Uemura H. Matsubara N, et al. Among authors: nasu y. Int J Clin Oncol. 2018 Feb;23(1):173-180. doi: 10.1007/s10147-017-1176-0. Epub 2017 Aug 2. Int J Clin Oncol. 2018. PMID: 28770408 Free PMC article. Clinical Trial.
Nationwide Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation (J-POPS): first analysis on survival.
Ito K, Saito S, Yorozu A, Kojima S, Kikuchi T, Higashide S, Aoki M, Koga H, Satoh T, Ohashi T, Nakamura K, Katayama N, Tanaka N, Nakano M, Shigematsu N, Dokiya T, Fukushima M; J-POPS Investigators. Ito K, et al. Int J Clin Oncol. 2018 Dec;23(6):1148-1159. doi: 10.1007/s10147-018-1309-0. Epub 2018 Jun 22. Int J Clin Oncol. 2018. PMID: 29934842
Three-year follow-up of a phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer and bone metastases.
Uemura H, Uemura H, Nagamori S, Wakumoto Y, Kimura G, Kikukawa H, Yokomizo A, Mizokami A, Kosaka T, Masumori N, Kawasaki Y, Yonese J, Nasu Y, Fukasawa S, Sugiyama T, Kinuya S, Hosono M, Yamaguchi I, Akagawa T, Matsubara N. Uemura H, et al. Among authors: nasu y. Int J Clin Oncol. 2019 May;24(5):557-566. doi: 10.1007/s10147-018-01389-4. Epub 2019 Mar 14. Int J Clin Oncol. 2019. PMID: 30875000 Free PMC article. Clinical Trial.
537 results